Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae-Min Kim

Showing results (141-150 of 613) with videos related to

Pageof 62
Sort By:
Anticancer Research|January 1, 2015
In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancerBhumsuk Keam, Soyeon Kim, Yong-Oon Ahn, et al.
Orthopaedic Journal of Sports Medicine|October 30, 2023
Biomechanical Comparison of 1.2-mm Suture Tape, 2.0-mm Suture Tape, and 0.5-mm Suture Using Various Arthroscopic Knot TechniquesSamuel Baek, Myung Ho Shin, Tae-Min Kim, et al.
AJR. American Journal of Roentgenology|December 25, 2014
CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expressionAvinash Kambadakone, Sam S Yoon, Tae-Min Kim, et al.
Insights Into Imaging|October 25, 2023
Prognostic utility of body composition parameters based on computed tomography analysis of advanced non-small cell lung cancer treated with immune checkpoint inhibitorsJi Eun Park, Jaemin Jo, Jeonghwan Youk, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion MutationsYusoo Lee, Tae Min Kim, Dong-Wan Kim, et al.
Diabetes Research and Clinical Practice|May 14, 2011
Life-threatening hypoglycemia induced by a tyrosine kinase inhibitor in a patient with neuroendocrine tumor: a case reportYenna Lee, Hye Seung Jung, Hyung Jin Choi, et al.
Korean Circulation Journal|October 25, 2011
Multimodality imaging can help to doubt, diagnose and follow-up cardiac massSeung-Pyo Lee, Eue-Keun Choi, Tae-Min Kim, et al.
Cancer Research and Treatment|May 23, 2023
Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerMiso Kim, Soyeon Kim, Jeemin Yim, et al.
Leukemia & Lymphoma|January 5, 2016
An increase in indoleamine 2,3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisoloneSoo Jeong Nam, Sehui Kim, Jin Ho Paik, et al.
Clinical Lung Cancer|June 6, 2019
First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysisRyul Kim, Bhumsuk Keam, Seokyung Hahn, et al.
Pageof 62

Showing results (141-150 of 613) with videos related to

Sort By:
Pageof 62
Anticancer Research|January 1, 2015
In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancerBhumsuk Keam, Soyeon Kim, Yong-Oon Ahn, et al.
Orthopaedic Journal of Sports Medicine|October 30, 2023
Biomechanical Comparison of 1.2-mm Suture Tape, 2.0-mm Suture Tape, and 0.5-mm Suture Using Various Arthroscopic Knot TechniquesSamuel Baek, Myung Ho Shin, Tae-Min Kim, et al.
AJR. American Journal of Roentgenology|December 25, 2014
CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expressionAvinash Kambadakone, Sam S Yoon, Tae-Min Kim, et al.
Insights Into Imaging|October 25, 2023
Prognostic utility of body composition parameters based on computed tomography analysis of advanced non-small cell lung cancer treated with immune checkpoint inhibitorsJi Eun Park, Jaemin Jo, Jeonghwan Youk, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion MutationsYusoo Lee, Tae Min Kim, Dong-Wan Kim, et al.
Diabetes Research and Clinical Practice|May 14, 2011
Life-threatening hypoglycemia induced by a tyrosine kinase inhibitor in a patient with neuroendocrine tumor: a case reportYenna Lee, Hye Seung Jung, Hyung Jin Choi, et al.
Korean Circulation Journal|October 25, 2011
Multimodality imaging can help to doubt, diagnose and follow-up cardiac massSeung-Pyo Lee, Eue-Keun Choi, Tae-Min Kim, et al.
Cancer Research and Treatment|May 23, 2023
Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerMiso Kim, Soyeon Kim, Jeemin Yim, et al.
Leukemia & Lymphoma|January 5, 2016
An increase in indoleamine 2,3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisoloneSoo Jeong Nam, Sehui Kim, Jin Ho Paik, et al.
Clinical Lung Cancer|June 6, 2019
First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysisRyul Kim, Bhumsuk Keam, Seokyung Hahn, et al.
Pageof 62